NeueHealth Total Current Liabilities vs Cash Analysis
| NEUE Stock | 4.86 0.14 2.80% |
NeueHealth financial indicator trend analysis is infinitely more than just investigating NeueHealth recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether NeueHealth is a good investment. Please check the relationship between NeueHealth Total Current Liabilities and its Cash accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in NeueHealth. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment. For information on how to trade NeueHealth Stock refer to our How to Trade NeueHealth Stock guide.
Total Current Liabilities vs Cash
Total Current Liabilities vs Cash Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of NeueHealth Total Current Liabilities account and Cash. At this time, the significance of the direction appears to have pay attention.
The correlation between NeueHealth's Total Current Liabilities and Cash is -0.79. Overlapping area represents the amount of variation of Total Current Liabilities that can explain the historical movement of Cash in the same time period over historical financial statements of NeueHealth, assuming nothing else is changed. The correlation between historical values of NeueHealth's Total Current Liabilities and Cash is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Total Current Liabilities of NeueHealth are associated (or correlated) with its Cash. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Cash has no effect on the direction of Total Current Liabilities i.e., NeueHealth's Total Current Liabilities and Cash go up and down completely randomly.
Correlation Coefficient | -0.79 |
| Relationship Direction | Negative |
| Relationship Strength | Weak |
Total Current Liabilities
Total Current Liabilities is an item on NeueHealth balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of NeueHealth are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.Cash
Cash refers to the most liquid asset of NeueHealth, which is listed under current asset account on NeueHealth balance sheet and usually includes currency, coins, checking accounts, and not deposited checks received from NeueHealth customers. The amounts must be unrestricted with restricted cash listed in a different NeueHealth account. The total amount of money in the form of currency that a company has in its possession. This includes all bills, coins, and funds in bank accounts.Most indicators from NeueHealth's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into NeueHealth current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in NeueHealth. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment. For information on how to trade NeueHealth Stock refer to our How to Trade NeueHealth Stock guide.At present, NeueHealth's Sales General And Administrative To Revenue is projected to slightly decrease based on the last few years of reporting.
| 2021 | 2022 | 2023 | 2024 (projected) | Total Revenue | 1.5B | 751.2M | 1.2B | 928.5M | Depreciation And Amortization | 35.0M | 30.7M | 18.3M | 20.6M |
NeueHealth fundamental ratios Correlations
Click cells to compare fundamentals
NeueHealth Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether NeueHealth is a strong investment it is important to analyze NeueHealth's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact NeueHealth's future performance. For an informed investment choice regarding NeueHealth Stock, refer to the following important reports:Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in NeueHealth. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment. For information on how to trade NeueHealth Stock refer to our How to Trade NeueHealth Stock guide.You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of NeueHealth. If investors know NeueHealth will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about NeueHealth listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Revenue Per Share 145.939 | Quarterly Revenue Growth 0.286 | Return On Assets (0.04) | Return On Equity (1.83) |
The market value of NeueHealth is measured differently than its book value, which is the value of NeueHealth that is recorded on the company's balance sheet. Investors also form their own opinion of NeueHealth's value that differs from its market value or its book value, called intrinsic value, which is NeueHealth's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because NeueHealth's market value can be influenced by many factors that don't directly affect NeueHealth's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between NeueHealth's value and its price as these two are different measures arrived at by different means. Investors typically determine if NeueHealth is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, NeueHealth's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.